MedPath

Porfimer Sodium

Generic Name
Porfimer Sodium
Brand Names
Photofrin
Drug Type
Small Molecule
CAS Number
87806-31-3
Unique Ingredient Identifier
Y3834SIK5F
Background

The purified component of hematoporphyrin derivative, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (hematoporphyrin photoradiation); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States.

Indication

临床上用于对不能用手术及其他根治疗法的肺、子宫颈癌或需非手术治疗的患者,在内镜下能观察到病灶的全貌、可能进行激光照射的下列疾病:早期肺癌(0期或Ⅰ期)、浅表性食管癌、浅表性早期胃癌、宫颈癌初期及发育异常。

Associated Conditions
Barrett's Esophagus, Esophageal Cancer, Completely obstructive Non-small cell lung cancer, Microinvasive endobrachial Non-small cell lung cancer, Partially obstructive Non-small cell lung cancer

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Phase 2
Terminated
Conditions
Brain Tumor, Recurrent
Interventions
First Posted Date
2013-10-22
Last Posted Date
2019-08-20
Lead Sponsor
Harry T Whelan, MD
Target Recruit Count
1
Registration Number
NCT01966809
Locations
🇺🇸

Medical College of Wisconsin/ Froedtert Hospital, Milwaukee, Wisconsin, United States

Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Phase 1
Completed
Conditions
Acinar Cell Adenocarcinoma of the Pancreas
Duct Cell Adenocarcinoma of the Pancreas
Stage III Pancreatic Cancer
Interventions
Procedure: endoscopic ultrasonography
Procedure: photodynamic therapy
First Posted Date
2013-01-17
Last Posted Date
2018-12-13
Lead Sponsor
John DeWitt
Target Recruit Count
12
Registration Number
NCT01770132
Locations
🇺🇸

IU Simon Cancer Center, Indianapolis, Indiana, United States

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Phase 1
Completed
Conditions
Brain Tumor, Recurrent
Interventions
First Posted Date
2012-09-11
Last Posted Date
2019-02-25
Lead Sponsor
Harry T Whelan, MD
Target Recruit Count
5
Registration Number
NCT01682746
Locations
🇺🇸

Children's Hospital of Wisconsin, Wauwatosa, Wisconsin, United States

Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Obstructive Jaundice
Interventions
First Posted Date
2012-01-09
Last Posted Date
2015-11-20
Lead Sponsor
Samsung Medical Center
Target Recruit Count
11
Registration Number
NCT01506115
Locations
🇰🇷

Samsung Medical Center 81 Irwon-Ro Gangnamgu, Seoul, Korea, Republic of

Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease

Completed
Conditions
Lung Cancer
Interventions
Procedure: bronchoscopy
First Posted Date
2008-09-18
Last Posted Date
2018-07-05
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
35
Registration Number
NCT00754910
Locations
🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Phase 2
Terminated
Conditions
Lung Cancer
Metastatic Cancer
Interventions
Drug: chemotherapy
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis
Procedure: spectroscopy
Procedure: therapeutic conventional surgery
First Posted Date
2008-01-28
Last Posted Date
2020-11-24
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Target Recruit Count
9
Registration Number
NCT00601848
Locations
🇺🇸

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat

Not Applicable
Terminated
Conditions
Head and Neck Cancer
Interventions
Drug: Photdynamic Therapy (PDT)
First Posted Date
2007-09-17
Last Posted Date
2014-07-04
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
30
Registration Number
NCT00530088
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

Phase 3
Completed
Conditions
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Interventions
Procedure: biliary stenting
First Posted Date
2007-08-08
Last Posted Date
2013-02-20
Lead Sponsor
University College, London
Target Recruit Count
92
Registration Number
NCT00513539
Locations
🇬🇧

Aintree University Hospital, Liverpool, England, United Kingdom

🇬🇧

Ninewells Hospital, Dundee, Scotland, United Kingdom

🇬🇧

University College Hospital, London, England, United Kingdom

and more 1 locations

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

Phase 2
Completed
Conditions
Head and Neck Cancer
Precancerous/Nonmalignant Condition
Interventions
Procedure: Photodynamic Therapy
First Posted Date
2007-03-28
Last Posted Date
2017-02-08
Lead Sponsor
University of Miami
Target Recruit Count
45
Registration Number
NCT00453336
Locations
🇺🇸

University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

Phase 1
Completed
Conditions
Superficial Bladder Cancer
Interventions
Procedure: Whole bladder laser light treatment as an alternative to radical cystectomy
First Posted Date
2006-05-08
Last Posted Date
2012-10-26
Lead Sponsor
North Florida/South Georgia Veterans Health System
Target Recruit Count
22
Registration Number
NCT00322699
Locations
🇺🇸

Malcom Randall NF/SG Veterans Administration Health System, Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath